<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two new B-cell lines, BALM-13 and BALM-14, were established from the bone marrow aspirate of a 13-year-old male patient with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>These cell lines are unique in their expression of CD antigens </plain></SENT>
<SENT sid="2" pm="."><plain>BALM-13 was characterized as belonging to the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> group III cell type (CD10-, CD20+, CD23+, D39+, CD77-), and BALM-14 to the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> group I cell type (CD10+, CD20+, CD23-, CD39-, CD77+) </plain></SENT>
<SENT sid="3" pm="."><plain>The expression of immunoglobulin chains of BALM-13 (lambda delta mu) differed from those of BALM-14 (lambda mu) </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, BALM-13 was positive for Epstein-Barr virus nuclear antigen but BALM-14 was negative </plain></SENT>
<SENT sid="5" pm="."><plain>This is a unique pair of cell lines having intraclonal phenotypic <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> </plain></SENT>
</text></document>